C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.
about
Physiological effects and therapeutic potential of proinsulin C-peptidePioglitazone in addition to metformin improves erythrocyte deformability in patients with Type 2 diabetes mellitus.A Molecular Level Understanding of Zinc Activation of C-peptide and its Effects on Cellular Communication in the Bloodstream.The clinical potential of C-peptide replacement in type 1 diabetes.C-peptide and zinc delivery to erythrocytes requires the presence of albumin: implications in diabetes explored with a 3D-printed fluidic device.Molecular effects of C-Peptide in microvascular blood flow regulation.C-Peptide replacement therapy in type 1 diabetes: are we in the trough of disillusionment?Mechanisms of C-peptide-mediated rescue of low O2-induced ATP release from erythrocytes of humans with type 2 diabetes.Low O2-induced ATP release from erythrocytes of humans with type 2 diabetes is restored by physiological ratios of C-peptide and insulin.Effects of detyrosinated tubulin on Na+,K+-ATPase activity and erythrocyte function in hypertensive subjects.
P2860
Q27012286-71F1F92B-EF9D-4BDF-8799-9CBB9FCFD21DQ33590082-D3B78DF0-FDF7-4687-BE7E-2C34DBBC7B3BQ33682566-FFC98E0C-B5A3-4431-8756-07493E238909Q35857755-7DCE1960-AD39-494A-AE4B-9DEA513D8B59Q38892829-8924A396-1FFF-4F5A-B610-9B3EF1003C2AQ39224550-D0CB9C93-EEEA-44C3-88BF-5D111B86AD18Q39420435-A7B9FC04-B545-46AD-B55F-3ADE51CE36D4Q48238409-124D63FC-337E-446C-9937-305A84514E4CQ50463857-0901C805-3173-4300-9FF1-E762ADE83378Q53658966-6A1918AD-67E7-4082-961B-DE71D0211BD1
P2860
C-peptide and its C-terminal fragments improve erythrocyte deformability in type 1 diabetes patients.
description
2008 nî lūn-bûn
@nan
2008 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
name
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@ast
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@en
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@nl
type
label
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@ast
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@en
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@nl
prefLabel
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@ast
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@en
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@nl
P2093
P2860
P356
P1476
C-peptide and its C-terminal f ...... y in type 1 diabetes patients.
@en
P2093
Karin Ekberg
Thomas Forst
Thomas Hach
Thomas Kunt
P2860
P304
P356
10.1155/2008/730594
P577
2008-01-01T00:00:00Z